PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients (pts) with localized or locally advanced high-risk prostate cancer (PC) Meeting Abstract
| Authors: | Kibel, A. S.; Gleave, M.; Brookman-May, S. D.; Kim, W.; Evans, C. P.; Efstathiou, E.; Kantoff, P. W.; Ross, A.; Shore, N. D.; Briganti, A.; Hadaschik, B. A.; Heidenreich, A.; Rooney, O. B.; Tian, S. K.; Wetherhold, L.; Xu, W.; Parsons, J. K.; Yeruva, K.; Taplin, M. E. |
| Abstract Title: | PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients (pts) with localized or locally advanced high-risk prostate cancer (PC) |
| Meeting Title: | 2022 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2022 Feb 17-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-20 |
| Language: | English |
| ACCESSION: | WOS:000771008900291 |
| DOI: | 10.1200/JCO.2022.40.6_suppl.TPS285 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS285 -- Meeting was conducted online as well as in person -- Source: Wos |
